unknown
Stage
1
Investors
About
AVEO Pharmaceuticals (Aveo Oncology) is a publicly traded biopharmaceutical company developing targeted medicines for oncology and other areas of unmet medical need. The company retains North American rights to its oncology portfolio while seeking partners for development and commercialization outside North America.
Explore AVEO Pharmaceuticals, Inc.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.